{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:23:51Z","timestamp":1772119431014,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T00:00:00Z","timestamp":1716336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T00:00:00Z","timestamp":1716336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"RJR fund"},{"name":"NIH\/NCI Cancer Center Support Gran","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]},{"name":"NIH\/NCI Cancer Center Support Gran","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]},{"name":"NIH\/NCI Cancer Center Support Gran","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]},{"name":"NIH\/NCI Cancer Center Support Gran","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]},{"name":"NIH\/NCI Cancer Center Support Gran","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]},{"name":"NIH\/NCI Cancer Center Support Gran","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","award":["P400PM_199318"],"award-info":[{"award-number":["P400PM_199318"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006447","name":"University of Zurich","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006447","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This study aimed to validate the Chemotherapy-Induced Alopecia Distress Scale (CADS) in a diverse English-speaking population and patients with endocrine treatment-induced alopecia (EIA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Chemotherapy and endocrine therapy commonly cause alopecia in breast cancer patients, leading to significant psychological and social challenges. The CADS was developed to assess the psychosocial impact of alopecia, but its generalizability beyond Korean patients requires further investigation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data from the CHANCE study (NCT02530177), which focused on non-metastatic breast cancer, was used. The cohort included 256 patients, and CADS data were collected at baseline, 6\u00a0months after chemotherapy completion, or 12\u00a0months after initiating endocrine therapy. The CADS questionnaire comprised 17 items covering physical and emotional health, daily activities, and relationships. Reliability was assessed using Cronbach\u2019s alpha, and responsiveness was measured by effect size.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The CADS exhibited good reliability, with Cronbach\u2019s alpha of 0.91 for the overall score, indicating acceptable internal consistency in both chemotherapy (0.89) and endocrine therapy (0.86) groups. Longitudinal responsiveness was supported by an effect size of 0.49 between decreasing satisfaction with hair growth and increasing emotional distress. Cross-sectional validity was confirmed, with effect sizes of 0.91 and 0.92 for satisfaction with hair growth and emotional and activity domains, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The CADS is a valid and responsive tool for assessing the psychosocial impact of chemotherapy-induced alopecia and endocrine treatment-induced alopecia in a diverse Western patient population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00520-024-08564-6","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T23:38:20Z","timestamp":1716334700000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Validation and responsiveness of the English version of the Chemotherapy-Induced Alopecia Distress Scale (CADS) in breast cancer patients"],"prefix":"10.1007","volume":"32","author":[{"given":"L.","family":"Kraehenbuehl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. S.","family":"Bang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. F.","family":"Ketosugbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Hay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujata","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Goldfarb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. E.","family":"Lacouture","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,22]]},"reference":[{"key":"8564_CR1","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.jaad.2018.03.055","volume":"80","author":"A Freites-Martinez","year":"2019","unstructured":"Freites-Martinez A, Shapiro J, Goldfarb S et al (2019) Hair disorders in patients with cancer. J Am Acad Dermatol 80:1179\u20131196. https:\/\/doi.org\/10.1016\/j.jaad.2018.03.055","journal-title":"J Am Acad Dermatol"},{"key":"8564_CR2","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1001\/jamadermatol.2018.0454","volume":"154","author":"A Freites-Martinez","year":"2018","unstructured":"Freites-Martinez A, Shapiro J, Chan D et al (2018) Endocrine therapy\u2013induced alopecia in patients with breast cancer. JAMA Dermatol 154:670\u2013675. https:\/\/doi.org\/10.1001\/jamadermatol.2018.0454","journal-title":"JAMA Dermatol"},{"key":"8564_CR3","doi-asserted-by":"publisher","first-page":"101840","DOI":"10.1016\/j.ejon.2020.101840","volume":"49","author":"V Boland","year":"2020","unstructured":"Boland V, Brady A-M, Drury A (2020) The physical, psychological and social experiences of alopecia among women receiving chemotherapy: an integrative literature review. Eur J Oncol Nurs 49:101840. https:\/\/doi.org\/10.1016\/j.ejon.2020.101840","journal-title":"Eur J Oncol Nurs"},{"key":"8564_CR4","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/pon.3531","volume":"23","author":"EK Choi","year":"2014","unstructured":"Choi EK, Kim IR, Chang O et al (2014) Impact of chemotherapy-induced alopecia distress on body image, psychosocial well-being, and depression in breast cancer patients. Psychooncology 23:1103\u20131110. https:\/\/doi.org\/10.1002\/pon.3531","journal-title":"Psychooncology"},{"key":"8564_CR5","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1001\/jamadermatol.2018.0454","volume":"154","author":"A Freites-Martinez","year":"2018","unstructured":"Freites-Martinez A, Shapiro J, Chan D et al (2018) Endocrine therapy-induced alopecia in patients with breast cancer. JAMA Dermatol 154:670\u2013675. https:\/\/doi.org\/10.1001\/jamadermatol.2018.0454","journal-title":"JAMA Dermatol"},{"key":"8564_CR6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00520-023-07704-8","volume":"31","author":"S Kocan","year":"2023","unstructured":"Kocan S, Aktug C, Gursoy A (2023) \u201cWho am I?\u201d A qualitative meta-synthesis of Chemotherapy-induced alopecia and body image perception in breast cancer patients. Support Care Cancer 31:237. https:\/\/doi.org\/10.1007\/s00520-023-07704-8","journal-title":"Support Care Cancer"},{"key":"8564_CR7","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1007\/s00520-021-06748-y","volume":"30","author":"A Versluis","year":"2022","unstructured":"Versluis A, van Alphen K, Dercksen W, de Haas H, van den Hurk C, Kaptein AA (2022) \u201cDear hair loss\u201d-illness perceptions of female patients with chemotherapy-induced alopecia. Support Care Cancer 30:3955\u20133963. https:\/\/doi.org\/10.1007\/s00520-021-06748-y","journal-title":"Support Care Cancer"},{"key":"8564_CR8","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1046\/j.1365-2648.2000.01295.x","volume":"31","author":"L Cowley","year":"2000","unstructured":"Cowley L, Heyman B, Stanton M, Milner SJ (2000) How women receiving adjuvant chemotherapy for breast cancer cope with their treatment: a risk management perspective. J Adv Nurs 31:314\u2013321. https:\/\/doi.org\/10.1046\/j.1365-2648.2000.01295.x","journal-title":"J Adv Nurs"},{"key":"8564_CR9","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/annonc\/mdt476","volume":"25","author":"J Cho","year":"2014","unstructured":"Cho J, Choi EK, Kim IR et al (2014) Development and validation of Chemotherapy-Induced Alopecia Distress Scale (CADS) for breast cancer patients. Ann Oncol 25:346\u2013351. https:\/\/doi.org\/10.1093\/annonc\/mdt476","journal-title":"Ann Oncol"},{"key":"8564_CR10","doi-asserted-by":"publisher","first-page":"4327","DOI":"10.1007\/s00520-019-05284-0","volume":"28","author":"W Cong","year":"2020","unstructured":"Cong W, Wu Y, Liu L, Hu M, Zhou C (2020) A Chinese version of the Chemotherapy-Induced Alopecia Distress Scale based on reliability and validity assessment in breast cancer patients. Support Care Cancer 28:4327\u20134336. https:\/\/doi.org\/10.1007\/s00520-019-05284-0","journal-title":"Support Care Cancer"},{"key":"8564_CR11","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jclinepi.2010.02.006","volume":"63","author":"LB Mokkink","year":"2010","unstructured":"Mokkink LB, Terwee CB, Patrick DL et al (2010) The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol 63:737\u2013745. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.02.006","journal-title":"J Clin Epidemiol"},{"key":"8564_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11136-005-1524-9","volume":"15","author":"MR de Boer","year":"2006","unstructured":"de Boer MR, Terwee CB, de Vet HCW, Moll AC, V\u00f6lker-Dieben HJM, van Rens GHMB (2006) Evaluation of cross-sectional and longitudinal construct validity of two vision-related quality of life questionnaires: the LVQOL and VCM1. Qual Life Res 15:233\u2013248. https:\/\/doi.org\/10.1007\/s11136-005-1524-9","journal-title":"Qual Life Res"},{"key":"8564_CR13","doi-asserted-by":"publisher","first-page":"e12500","DOI":"10.1200\/JCO.2018.36.15_suppl.e12500","volume":"36","author":"ME Lacouture","year":"2018","unstructured":"Lacouture ME, Freites-Martinez A, Patil S et al (2018) The CHANCE study: a prospective, longitudinal study of chemotherapy and hormonal therapy induced hair changes and alopecia, skin aging and nail changes in women with non-metastatic breast cancer. J Clin Oncol 36:e12500\u2013e12500. https:\/\/doi.org\/10.1200\/JCO.2018.36.15_suppl.e12500","journal-title":"J Clin Oncol"},{"key":"8564_CR14","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1080\/028418699432842","volume":"38","author":"L Lent","year":"1999","unstructured":"Lent L, Hahn E, Eremenco S, Webster K, Cella D (1999) Using cross-cultural input to adapt the Functional Assessment of Chronic Illness Therapy (FACIT) scales. Acta Oncol 38:695\u2013702. https:\/\/doi.org\/10.1080\/028418699432842","journal-title":"Acta Oncol"},{"key":"8564_CR15","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3102\/10769986027004335","volume":"27","author":"DG Bonett","year":"2002","unstructured":"Bonett DG (2002) Sample size requirements for testing and estimating coefficient alpha. J Educ Behav Stat 27:335\u2013340. https:\/\/doi.org\/10.3102\/10769986027004335","journal-title":"J Educ Behav Stat"},{"key":"8564_CR16","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1177\/001316446502500428","volume":"25","author":"LR Aiken","year":"1965","unstructured":"Aiken LR (1965) Book Reviews: Measuring educational achievement by Robert L. Ebel. Englewood Cliffs, N. J.: Prentice-Hall, 1965. pp. xii + 481. Educ Psychol Meas 25:1167\u20131169. https:\/\/doi.org\/10.1177\/001316446502500428","journal-title":"Educ Psychol Meas"},{"key":"8564_CR17","doi-asserted-by":"publisher","first-page":"795672","DOI":"10.3389\/fpsyt.2021.795672","volume":"12","author":"LE van Zyl","year":"2021","unstructured":"van Zyl LE, Ten Klooster PM (2021) Exploratory structural equation modeling: practical guidelines and tutorial with a convenient online tool for Mplus. Front Psychiatry 12:795672. https:\/\/doi.org\/10.3389\/fpsyt.2021.795672","journal-title":"Front Psychiatry"},{"key":"8564_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10705519909540118","volume":"6","author":"Hu Lt","year":"1999","unstructured":"Lt Hu, Bentler PM (1999) Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Modeling 6:1\u201355. https:\/\/doi.org\/10.1080\/10705519909540118","journal-title":"Struct Equ Modeling"},{"key":"8564_CR19","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/cncr.30369","volume":"123","author":"JA de Souza","year":"2017","unstructured":"de Souza JA, Yap BJ, Wroblewski K et al (2017) Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the COmprehensive Score for financial Toxicity (COST). Cancer 123:476\u2013484. https:\/\/doi.org\/10.1002\/cncr.30369","journal-title":"Cancer"},{"key":"8564_CR20","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511996214","volume-title":"Measurement in medicine: a practical guide","author":"HCW De Vet","year":"2011","unstructured":"De Vet HCW, Terwee CB, Mokkink LB, Knol DL (2011) Measurement in medicine: a practical guide. Cambridge University Press"},{"issue":"5","key":"8564_CR21","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/s0895-4356(99)00206-1","volume":"53","author":"JA Husted","year":"2000","unstructured":"Husted JA, Cook RJ, Farewell VT, Gladman DD (2000) Methods for assessing responsiveness: a critical review and recommendations. J Clin Epidemiol 53(5):459\u201368. https:\/\/doi.org\/10.1016\/s0895-4356(99)00206-1","journal-title":"J Clin Epidemiol"},{"key":"8564_CR22","unstructured":"Food U, Administration D (2018) The voice of the patient. A series of reports from the US Food and Drug Administration\u2019s (FDA\u2019s) Patient-Focused Drug Development Initiative. Lung Cancer. Available from: http:\/\/wayback.archive-it.org\/7993\/20171114193841\/, https:\/\/www.fda.gov\/ForIndustry\/UserFees\/PrescriptionDrugUserFee\/ucm353273.htm. Accessed 28 Feb"},{"key":"8564_CR23","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.4103\/sja.SJA_203_17","volume":"11","author":"S Tsang","year":"2017","unstructured":"Tsang S, Royse CF, Terkawi AS (2017) Guidelines for developing, translating, and validating a questionnaire in perioperative and pain medicine. Saudi J Anaesth 11:S80-s89. https:\/\/doi.org\/10.4103\/sja.SJA_203_17","journal-title":"Saudi J Anaesth"},{"key":"8564_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/BF02294210","volume":"49","author":"B Muth\u00e9n","year":"1984","unstructured":"Muth\u00e9n B (1984) A general structural equation model with dichotomous, ordered categorical, and continuous latent variable indicators. Psychometrika 49:115\u2013132","journal-title":"Psychometrika"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08564-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-024-08564-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08564-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T08:12:15Z","timestamp":1718611935000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-024-08564-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,22]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["8564"],"URL":"https:\/\/doi.org\/10.1007\/s00520-024-08564-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.11.05.23298093","asserted-by":"object"}]},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,22]]},"assertion":[{"value":"6 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"LK, DK, KFK, ASB, JH, SG and JC declare no conflict of interest; SP is a consultant for ByHeart, MEL: has a consultant role with Johnson and Johnson, Novocure, QED, Bicara, Janssen, Novartis, F. Hoffmann-La Roche AG, EMD Serono, Astrazeneca, Innovaderm, Deciphera, DFB, Azitra, Kintara, RBC\/La Roche Posay, Trifecta, Varsona, Genentech, Loxo, Seattle Genetics, Lutris, OnQuality, Azitra, Roche, Oncoderm, NCODA, Apricity. MEL also receives research funding from Lutris, Paxman, Novocure, J&J, US Biotest, OQL, Novartis, and AZ","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"369"}}